Biocon revenue growth

Stocks

Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Byaea2ede5_admin November 11, 2025

Biocon Group on Tuesday reported a 20% year-on-year increase in operating revenue in the second quarter of FY26 to Rs 4,296 crore, driven by robust growth in biosimilars, improved momentum in generics, and a steady contribution from the CRDMO segment. EBITDA grew 29% to Rs 928 crore, while net profit for the period stood at…

Read More Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Stocks

Biocon reports 95% YoY decline in net profit, operating revenue up 15%
Byaea2ede5_admin August 7, 2025

Biocon posted a 95% year-on-year decline in reported net profit in the first quarter ended-June. However, the company claims to have on a like-for-like basis booked a 65% increase in profit after tax, after adjusting for the one-time divestment gains it made in the same quarter a year ago from the sale of metabolic, oncology…

Read More Biocon reports 95% YoY decline in net profit, operating revenue up 15%